|
|
|
|
||
Re: conference call q and aSo here's a question the standard measure used thus far has been s-antigen which might be the reasonable way to gauge progress but how do you think they will test for cccdna in the number of patients and frequency of samples they are evaluating?? would they need to do PCR for each patient and sample?? Is that even practical ? How will we know that the other targets are effective ? |
return to message board, top of board |